Neurosense Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Neurosense Therapeutics (NRSN) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Neurosense Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Neurosense Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurosense Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $18k | 15k | 1.25 |
| 2025-06-30 | $3.0k | 1.6k | 1.89 |
| 2025-03-31 | $2.1k | 2.3k | 0.93 |
| 2024-03-31 | $22k | 12k | 1.82 |
| 2023-12-31 | $4.3k | 5.5k | 0.78 |
| 2023-09-30 | $6.9k | 9.7k | 0.71 |
| 2023-03-31 | $8.2k | 4.8k | 1.72 |
| 2022-12-31 | $5.0k | 4.1k | 1.22 |
| 2022-09-30 | $3.0k | 1.8k | 1.64 |
| 2022-06-30 | $45k | 13k | 3.35 |
| 2022-03-31 | $7.0k | 1.9k | 3.72 |
| 2021-12-31 | $20k | 8.0k | 2.49 |